133PA study evaluating the different treatment modalities for EGFR mutation positive advanced NSCLC patients that acquire c-MET amplification after EGFR TKI therapy resistant
Qu, J, Liu, L, Heng, J, Zhou, C, Xiong, Y, Jiang, W, Yang, NVolume:
30
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz063.031
Date:
April, 2019
File:
PDF, 76 KB
english, 2019